22nd Century Group, Inc. (XXII) Stock Price & Analysis
22nd Century Group, Inc. (XXII) fell 8.17% to USD 4.27 as of July 25, 2026 at 04:34 UTC, according to Nexqual real-time market data.
XXII last closed at USD 4.65; the session ranged USD 4.2–4.65 on volume of 8,162 shares. Market capitalization is $1.47M, with a 52-week range of USD 3.74–1,179 (NCM). Source: Nexqual, July 25, 2026 at 04:34 UTC.
Key Statistics (as of July 25, 2026 at 04:34 UTC)
| Price | USD 4.27 |
|---|---|
| Change | ▼ 8.17% (down) |
| Previous Close | USD 4.65 |
| Open | USD 4.65 |
| Day Range | USD 4.2 – 4.65 |
| 52-Week Range | USD 3.74 – 1,179 |
| Volume | 8,162 shares |
| Market Cap | $1.47M |
| Exchange | NCM |
Technical Analysis (XXII)
Nexqual's technical model rates XXII "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 04:34 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 34.43 (neutral) |
| vs SMA50 | Below (USD 7.24) |
| MACD | -1.07 (negative) |
Analyst Ratings (XXII)
Wall Street analysts rate XXII "None", per Nexqual as of July 25, 2026 at 04:34 UTC.
| Consensus Rating | None |
|---|
Earnings (XXII)
| Next Earnings Date | 2026-08-14 |
|---|
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -361.6 vs est -24 ▼ miss |
| 2025-12-31 | USD -117.8 vs est -42 ▼ miss |
Source: Nexqual, July 25, 2026 at 04:34 UTC.
Financials & Fundamentals (XXII)
| Total Revenue | $6.06M |
|---|---|
| Revenue Growth (YoY) | -43.30% |
| Gross Margin | -52.19% |
| Operating Margin | -235.76% |
| Profit Margin | -65.76% |
| ROE | -103.55% |
| Debt / Equity | 6.2 |
| Current Ratio | 2.67 |
| Total Cash | $9.54M |
| Total Debt | $1.32M |
| Free Cash Flow | $-13.15M |
Source: Nexqual, July 25, 2026 at 04:34 UTC.
Financial Health Score (XXII)
Nexqual rates 22nd Century Group, Inc.'s overall financial health "Weak" across five dimensions, as of July 25, 2026 at 04:34 UTC.
| Growth | Critical — Revenue -43% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $10M cash vs $1M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$13M, burning cash |
| Efficiency | Critical — ROE -104%, ROA -28.3% |
Ownership (XXII)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +10.35% |
| Shares Outstanding | 345,124 |
| Float | 188,211 |
| Short % of Float | +4.59% |
Source: Nexqual, July 25, 2026 at 04:34 UTC.
Leadership (XXII)
22nd Century Group, Inc. is led by Lawrence D. Firestone (age 67), President, CEO & Chairman, per Nexqual as of July 25, 2026 at 04:34 UTC.
| President, CEO & Chairman | Lawrence D. Firestone (age 67) |
|---|---|
| CFO & Principal Accounting Officer | Daniel A. Otto (age 35) |
| Vice President of Operations | Scott Marion (age 45) |
| Senior Vice President of Sales & Marketing | Robert P. Manfredonia (age 60) |
| Director of Science & Technology | Kimberly Farr |
Major Backers & Investors (XXII)
Notable institutional backers of 22nd Century Group, Inc. include Anson Funds Management LP, Fidelity, according to Nexqual as of July 25, 2026 at 04:34 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Anson Funds Management LP | 0.49% |
| Fidelity | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 0.15% |
Source: Nexqual, July 25, 2026 at 04:34 UTC.
From 22nd Century Group, Inc.'s Latest SEC 10-K Filing (filed 2026-03-26)
Key Strengths & Strategy (as disclosed to the SEC)
- 22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States.
- The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products.
- It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Mocksville, North Carolina.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TVRD | Tvardi Therapeutics, Inc. | USD 2.51 | ▼ 9.06% |
| DOGP | Dogecoin Cash Inc. | USD 0.01 | ▼ 7.23% |
| CANN | TREES Corporation | USD 0.03 | ▲ 8.05% |
| CVSI | CV Sciences, Inc. | USD 0.02 | ▲ 0% |
| IGC | IGC Pharma, Inc. | USD 0.26 | ▼ 2.22% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:34 UTC. This page is informational and not investment advice.